| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/31/2008 | CN100446786C Technique for producing extract product of mulberry bark |
| 12/31/2008 | CN100446785C Peppermint oil dripping pills and its prepn. method |
| 12/31/2008 | CN100446784C Chinese medicine for colitis and its preparation process |
| 12/31/2008 | CN100446783C Method for preparing injection of astragalus |
| 12/31/2008 | CN100446780C Method for preparing injection preparation of freeze drying powder of Xuesaitong |
| 12/31/2008 | CN100446779C Method for preparing acanthopanax senticousus extracting liquid/extraction |
| 12/31/2008 | CN100446778C Method of preparing solution / substance extracted from ginkgo leaves |
| 12/31/2008 | CN100446776C Superoxide anion decomposing agent |
| 12/31/2008 | CN100446775C Chonsurid for venous injection administration and its preparing method |
| 12/31/2008 | CN100446774C Clindamycin hydrochloride vaginal effervescent tablet and its preparing method |
| 12/31/2008 | CN100446773C Compound micro-cream for acne treatment and preparation method thereof |
| 12/31/2008 | CN100446770C Water aerosol containing beclomethasone dipropionate |
| 12/31/2008 | CN100446769C Medicine releasing composition for improving steroid compound stability |
| 12/31/2008 | CN100446768C Mosapride citrate capsule and preparation process thereof |
| 12/31/2008 | CN100446766C Albendazole new form for treating nasal polyp and nasal polyp diseases |
| 12/31/2008 | CN100446765C Albendazole new form for treating chronic rhinitis |
| 12/31/2008 | CN100446764C Vitamic C controlled release pill and its preparation method and use |
| 12/31/2008 | CN100446763C Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 12/31/2008 | CN100446762C (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 12/31/2008 | CN100446759C Gastrodine tablets disintegrating in oral cavity and process for producing same |
| 12/31/2008 | CN100446758C Improved malus asiatica soft capsule and its preparation method |
| 12/31/2008 | CN100446757C Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 12/31/2008 | CN100446756C Preparation of composite drug-loaded nanoparticles of carboxyl-chitosan and chitosan modified by glycyrrhizanates |
| 12/31/2008 | CN100446755C Incense-fuming solid-state formulation for treating nasitis and reagent bottle equipped with same |
| 12/31/2008 | CN100446754C Prepn process of skin icing snake fat ointment |
| 12/31/2008 | CN100446753C Clotrimazole gel, and its prepn. method |
| 12/31/2008 | CN100446740C Cotton bar, cotton bar type suppository and preparing technique |
| 12/31/2008 | CN100446688C Method for preparing medicinal lining for preventing and treating mammary glands hyperplasia and application thereof |
| 12/31/2008 | CA2728386A1 Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| 12/31/2008 | CA2698143A1 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 12/31/2008 | CA2694238A1 Pharmaceutical aerosol compositions comprising fluticasone |
| 12/31/2008 | CA2692165A1 Compositions of specific binding agents to hepatocyte growth factor |
| 12/31/2008 | CA2691956A1 Improved pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| 12/31/2008 | CA2691667A1 Method for the production of a pharmaceutical containing tadalafil |
| 12/31/2008 | CA2691597A1 Microspheres having core/shell structure |
| 12/31/2008 | CA2691596A1 Percutaneous absorption type patch |
| 12/31/2008 | CA2691571A1 An inhalable composition |
| 12/31/2008 | CA2691531A1 Formation of stable submicron peptide or protein particles by thin film freezing |
| 12/31/2008 | CA2691371A1 Duloxetine formulation |
| 12/31/2008 | CA2690471A1 Nanocapsules with liquid lipidic core loaded with water-soluble or water-dispersible ingredient(s) |
| 12/31/2008 | CA2689960A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 12/31/2008 | CA2689572A1 A bioerodible patch |
| 12/31/2008 | CA2689330A1 Combination formulations |
| 12/31/2008 | CA2689048A1 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide |
| 12/31/2008 | CA2688494A1 Laser marked dosage forms |
| 12/30/2008 | US7470840 Self-assembly of nanoparticles at the interface between two fluids; multiple ligands or ligands with multiple functionalities can be attached to the nanoparticles to promote the interfacial segregation and assembly; spherical capsule for drug delivery |
| 12/30/2008 | US7470817 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 12/30/2008 | US7470802 hydroxy, alkoxy, amino, sulfo or carboxy terminated polyether is linked to an fatty acid acrylated polyol through ester, amide or thioester linkage; useful intermediates for preparing aggregates that can be used in drug delivery applications; for encapsulating a therapeutical agent |
| 12/30/2008 | US7470781 Formulation of stabilized cationic transfection agent(s)/nucleic acid particles |
| 12/30/2008 | US7470738 Non-aqueous absorbent and use thereof |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470666 injecting an aqueous solution containing dissolved freeze-dried ulinastatin powder; glycoprotein isolated from human urine, and also called human urine trypsin enzyme inhibitor |
| 12/30/2008 | US7470437 Utilizing nanocrystalline silver metal, alloy or compound for mucosal, serosal, respiratory, circulatory and/or musculo-skeletal conditions |
| 12/30/2008 | US7470436 Water-soluble composition containing coenzyme Q10 |
| 12/30/2008 | US7470435 Pellets containing binder |
| 12/30/2008 | US7470434 Methods and compositions for blocking microbial adherence to eukaryotic cells |
| 12/30/2008 | US7470433 Topical mixtures of estrogens or progesterones, and drug delivery vehicles comprising alcohols, alcohols-2+ or polyoxyalylene glycols, and permeation enhancer comprising a monoalkyl ether of diethylene glycol |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | US7470423 Aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants |
| 12/30/2008 | US7470422 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 12/30/2008 | US7470421 Delivery of diazepam through an inhalation route |
| 12/30/2008 | US7470397 Disintegratable films for diagnostic devices |
| 12/30/2008 | US7470267 Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method |
| 12/30/2008 | US7470266 Fluid medication delivery device |
| 12/30/2008 | US7470253 Fluid delivery apparatus with adjustable flow rate control |
| 12/30/2008 | US7469488 Control of process humidity to produce large, porous particles |
| 12/30/2008 | CA2512315C Biodegradable ocular implant |
| 12/30/2008 | CA2501601C Method of treating insulin resistance, adult onset diabetes and metabolic syndrome x using small unilamellar vesicles |
| 12/30/2008 | CA2495527C New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 12/30/2008 | CA2432546C Gel for the treatment of cats and dogs |
| 12/30/2008 | CA2388933C Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 12/30/2008 | CA2355269C Materials and methods for making improved micelle compositions |
| 12/30/2008 | CA2352676C Composition and method for treatment of symptoms associated with insufficient estrogen production |
| 12/30/2008 | CA2327398C Methods and compositions for stabilizing acetylcholine compositions |
| 12/30/2008 | CA2304958C Bioadhesive compositions and methods for topical administration of active agents |
| 12/30/2008 | CA2299423C Taste-masked pharmaceutical composition |
| 12/30/2008 | CA2294243C Novel cyanoaziridines for treating cancer |
| 12/30/2008 | CA2288482C Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis, dermatitis and dermatosis |
| 12/30/2008 | CA2285389C Use of cytoskeletal inhibitors for the prevention of restenosis |
| 12/30/2008 | CA2282506C Improved delivery of drugs to mucosal surfaces |
| 12/30/2008 | CA2281251C Sterol esters in tableted solid dosage forms |
| 12/30/2008 | CA2263816C Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 12/30/2008 | CA2218929C Compositions in glassy phase, stabilised by a sugar |
| 12/30/2008 | CA2189351C Narcotic containing aerosol formulation |
| 12/30/2008 | CA2144425C Microparticules bearing antigens and their use for the introduction of humoral and cell responses |
| 12/26/2008 | CA2635464A1 Process for treating rhinitis |
| 12/25/2008 | US20080319424 Devices and Methods for Delivering Therapeutic Substances for the Treatment of Sinusitis and Other Disorders |
| 12/25/2008 | US20080319392 Microneedle transport device |
| 12/25/2008 | US20080319377 Medical Device for Generating Transient Bubbles |
| 12/25/2008 | US20080319085 Titration dosing regimen for controlled release tramadol |
| 12/25/2008 | US20080319006 Nebulizer Formulation |
| 12/25/2008 | US20080318994 Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment |
| 12/25/2008 | US20080318993 Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment |
| 12/25/2008 | US20080318895 Intranasal delivery of nucleic acid molecules |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318788 Microcapsule |
| 12/25/2008 | US20080318245 Alumina; phopholipid; arrays, membrane biochips, and protein biochips; affinity purification, catalysis |
| 12/25/2008 | US20080317938 Dietary Fiber Delivery System |
| 12/25/2008 | US20080317902 Chewing Gum |
| 12/25/2008 | US20080317866 Collagen-based microspheres and methods of preparation and uses thereof |